These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8516290)

  • 1. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
    Le Beau MM; Espinosa R; Neuman WL; Stock W; Roulston D; Larson RA; Keinanen M; Westbrook CA
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5484-8. PubMed ID: 8516290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletions of chromosome 5 in malignant myeloid disorders.
    Le Beau MM
    Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.
    Zhao N; Stoffel A; Wang PW; Eisenbart JD; Espinosa R; Larson RA; Le Beau MM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6948-53. PubMed ID: 9192672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.
    Le Beau MM; Espinosa R; Davis EM; Eisenbart JD; Larson RA; Green ED
    Blood; 1996 Sep; 88(6):1930-5. PubMed ID: 8822909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).
    Lai F; Godley LA; Joslin J; Fernald AA; Liu J; Espinosa R; Zhao N; Pamintuan L; Till BG; Larson RA; Qian Z; Le Beau MM
    Genomics; 2001 Jan; 71(2):235-45. PubMed ID: 11161817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
    Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
    Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome.
    Jaju RJ; Boultwood J; Oliver FJ; Kostrzewa M; Fidler C; Parker N; McPherson JD; Morris SW; Müller U; Wainscoat JS; Kearney L
    Genes Chromosomes Cancer; 1998 Jul; 22(3):251-6. PubMed ID: 9624537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval.
    Horrigan SK; Westbrook CA; Kim AH; Banerjee M; Stock W; Larson RA
    Blood; 1996 Oct; 88(7):2665-70. PubMed ID: 8839861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q).
    Le Beau MM; Lemons RS; Espinosa R; Larson RA; Arai N; Rowley JD
    Blood; 1989 Feb; 73(3):647-50. PubMed ID: 2783863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization for del(5q) in myelodysplasia/acute myeloid leukemia: comparison of EGR1 vs. CSF1R probes and diagnostic yield over metaphase cytogenetics alone.
    Sun Y; Cook JR
    Leuk Res; 2010 Mar; 34(3):340-3. PubMed ID: 19608274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q.
    Le Beau MM; Epstein ND; O'Brien SJ; Nienhuis AW; Yang YC; Clark SC; Rowley JD
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5913-7. PubMed ID: 3497400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cDNA cloning and genomic structure of three genes localized to human chromosome band 5q31 encoding potential nuclear proteins.
    Lai F; Godley LA; Fernald AA; Orelli BJ; Pamintuan L; Zhao N; Le Beau MM
    Genomics; 2000 Nov; 70(1):123-30. PubMed ID: 11087669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment.
    Pedersen B
    Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
    Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
    Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the ovine genes encoding IL3, IL4, IL5, and CSF2 to sheep chromosome 5q13-q15 by FISH.
    Hawken RJ; Broom MF; van Stijn TC; Lumsden JM; Broad TE; Maddox JF
    Mamm Genome; 1996 Nov; 7(11):858-9. PubMed ID: 8875898
    [No Abstract]   [Full Text] [Related]  

  • 17. Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map.
    Wang PW; Eisenbart JD; Espinosa R; Davis EM; Larson RA; Le Beau MM
    Genomics; 2000 Jul; 67(1):28-39. PubMed ID: 10945467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
    Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
    Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders.
    Döhner K; Brown J; Hehmann U; Hetzel C; Stewart J; Lowther G; Scholl C; Fröhling S; Cuneo A; Tsui LC; Lichter P; Scherer SW; Döhner H
    Blood; 1998 Dec; 92(11):4031-5. PubMed ID: 9834205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
    MacKinnon RN; Kannourakis G; Wall M; Campbell LJ
    Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.